Trial intelligence / Profile preview

BiLe Trial: White Test for Bile Leakage Prevention

NCT04523701Phase 3Recruiting

Start
Mar 2021
Primary completion
Dec 2025
Modality
Lipid-based Nanoparticles
Countries
1
01

Overview

A Phase 3 trial of SMOFlipid in bile duct leak. Started Mar 2021; status: recruiting.

02

Drugs

SMOFlipid
03

Conditions

bile duct leak

Beyond the preview

Go deeper on NCT04523701.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04523701.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call